Tanaken
Tanaken (1450.T) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Tanaken (1450.T), covering cash flow, earnings, and balance sheets.
Tanaken (1450.T) Income Statement & Financial Overview
Review Tanaken 1450.T income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $3.51B | $3.14B | $3.05B | $2.58B |
| Cost of Revenue | $2.62B | $2.27B | $2.23B | $1.88B |
| Gross Profit | $882.13M | $865.00M | $820.00M | $706.00M |
| Gross Profit Ratio | $0.25 | $0.28 | $0.27 | $0.27 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $313.95M | $230.00M | $213.00M | $224.00M |
| Operating Expenses | $313.95M | $230.00M | $213.00M | $224.00M |
| Total Costs & Expenses | $2.94B | $2.50B | $2.45B | $2.10B |
| Interest Income | $33000.00 | $4.82M | $3.21M | $2.00M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $13.49M | $13.00M | $12.64M | $12.30M |
| EBITDA | $583.62M | $654.19M | $623.95M | $495.00M |
| EBITDA Ratio | $0.17 | $0.21 | $0.20 | $0.19 |
| Operating Income | $568.18M | $635.00M | $607.00M | $482.00M |
| Operating Income Ratio | $0.16 | $0.20 | $0.20 | $0.19 |
| Other Income/Expenses (Net) | $36.12M | $6.00M | $5.00M | -$3.00M |
| Income Before Tax | $604.30M | $641.00M | $612.00M | $479.00M |
| Income Before Tax Ratio | $0.17 | $0.20 | $0.20 | $0.19 |
| Income Tax Expense | $108.24M | $242.00M | $230.00M | $180.00M |
| Net Income | $496.06M | $399.00M | $382.00M | $299.00M |
| Net Income Ratio | $0.14 | $0.13 | $0.13 | $0.12 |
| EPS | $57.03 | $45.87 | $43.84 | $34.47 |
| Diluted EPS | $57.03 | $45.87 | $43.84 | $34.47 |
| Weighted Avg Shares Outstanding | $8.70M | $8.70M | $8.70M | $8.70M |
| Weighted Avg Shares Outstanding (Diluted) | $8.70M | $8.70M | $8.70M | $8.70M |
Financial performance has remained strong, with revenue growing from $2.58B in Q1 2024 to $3.51B in Q4 2024. Gross profit continued to perform well, with margins at 25% in the latest quarter. Operating income reached $568.18M in Q4 2024, holding a steady 16% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $583.62M. Net income rose to $496.06M, keeping EPS at $57.03. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan